title: Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.
authors.affiliation: Stanford Medical Center, Stanford, CA, USA.
authors.forename: Joanna
authors.initials: J
authors.lastname: Badger
authors.forename: Sewon
authors.initials: S
authors.lastname: Kang
authors.forename: Alison
authors.initials: A
authors.lastname: Uzieblo
authors.forename: Sandy
authors.initials: S
authors.lastname: Srinivas
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007249:Inflammation; D015603:Keratinocytes / Q000502:physiology; D008297:Male; D010787:Photosensitivity Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010789:Phototherapy; D014466:Ultraviolet Rays; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D000305:Adrenal Cortex Hormones; D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine